Back to News
Market Impact: 0.7

The Zombie Stock List Makes Another Call For Five9

FIVNZMNICEMSFTSAPCRMCSCOEGHTTWLORNG
Company FundamentalsCorporate EarningsCorporate Guidance & OutlookAnalyst InsightsShort Interest & ActivismMarket Technicals & FlowsTechnology & Innovation
The Zombie Stock List Makes Another Call For Five9

Five9 (FIVN) has been reinstated to the "Zombie Stock List" due to its critical cash burn, with cash on hand decreasing to $636 million, providing only a 24-month runway. Despite 12% YoY total revenue growth in 2Q25, the company exhibits decelerating growth, persistent unprofitability, and the industry's lowest margins. Analysts deem its current $26/share valuation highly unrealistic, implying growth and profitability far exceeding historical performance and industry averages, suggesting significant downside risk and a likely need for expensive capital raises to avert bankruptcy.

Analysis

Five9, Inc. (FIVN) has been reclassified as a "Zombie Stock" due to a critical deterioration in its liquidity position, signaling heightened financial risk. The company's cash on hand has plummeted from $1.1 billion to $636 million over the trailing twelve months (TTM), leaving it with an estimated 24-month cash runway based on its TTM free cash flow (FCF) burn of -$299 million. While the company reported 12% year-over-year revenue growth in 2Q25 and raised its full-year 2025 revenue guidance to 10% growth, this masks a significant trend of deceleration from 40% growth in 2021. Furthermore, this guided growth rate of 10% lags substantially behind the projected cloud-based contact center market's annual growth of 22%. Profitability remains a core weakness; Five9 has not generated annual profits since 2019, its TTM Net Operating Profit After Tax (NOPAT) is negative at -$5 million, and its ROIC of -1% ranks last among peers such as Microsoft, Nice Ltd., and Cisco. The current valuation at $26 per share appears fundamentally disconnected from reality, as a reverse DCF analysis indicates it implies a 23% revenue CAGR through 2034 and an immediate NOPAT margin improvement to 4%—levels that are multiples of its historical best and far exceed consensus forecasts. A more conservative DCF scenario, using consensus growth rates and the company's record NOPAT margin, suggests a fair value of just $6 per share, indicating a potential 77% downside.

AllMind AI Terminal